Tests a heart rhythm monitor in people after an acute ischemic stroke
Checks how often a implanted heart monitor finds atrial fibrillation after stroke.
Plain-language title generated from the registry record
Registry title: Yield of Implantable Cardiac Monitoring Device in Patients With Acute Ischemic Stroke.
Key facts
- Where
- Athens, GreeceSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 100 years old?
Source: NCT05494034, who can take part
Where in Greece
- Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, GreeceAthens, GreeceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- National and Kapodistrian University of Athens
- Trial code
- NCT05494034
- Record updated
- 9 November 2023
- Original description
In this prospective cohort study, the investigators aim to investigate the incidence of ICM-detected AF in unselected ischemic stroke patients and its association with anticoagulation initiation and stroke recurrence.Read full original descriptionShow less
Yield of Implantable Cardiac Monitoring Device in Patients With Acute Ischemic Stroke.
In this prospective cohort study, the investigators aim to investigate the incidence of ICM-detected AF in unselected ischemic stroke patients and its association with anticoagulation initiation and stroke recurrence.
Inclusion: Consecutive acute ischemic stroke or TIA patients aged 40 years or older will be enrolled; Diagnosis of acute ischemic stroke will be based on clinical and neuroimaging evaluation [brain computed tomography (CT) scan or magnetic resonance imaging (MRI) scan]; Stroke patients of all other etiologies (apart AF) presenting a HAVOC score ≥4 will be included in the study; Informed consent for participation in the study will be obtained from the patients or guardians of patients.
Exclusion: Patients with incomplete evaluation will be excluded, as previously described. [22] -Patients with known or newly detected AF at hospitalization will also be excluded; Not providing informed consent.